Please ensure Javascript is enabled for purposes of website accessibility
Contact us Contact Us
EN
Home > Featured Products > Oncology Research > Prostate Cancer

Prostate Cancer Research Reagents

Prostate cancer is the most common non-skin cancer in men. Biomarker-driven research — from PSA-based screening to PSMA-targeted theranostics — is transforming diagnosis and treatment. abinScience provides antibodies, proteins, and kits targeting PSA/KLK3, PSMA/FOLH1, androgen receptor (AR), TMPRSS2-ERG, and STEAP1 for prostate cancer research. RUO

Key Biomarkers & Targets

PSA / KLK3
Prostate-Specific Antigen
The most widely used prostate cancer screening biomarker. 60+ antibodies and recombinant proteins for ELISA and immunoassay development.
Antibodies • Proteins
PSMA
FOLH1 / GCPII
Overexpressed in prostate cancer; therapeutic and imaging target (lutetium-177 PSMA, 68Ga-PSMA PET). 47 antibodies and biosimilar proteins.
Antibodies • Proteins • Biosimilars
AR
Androgen Receptor
Central driver of prostate cancer; target of enzalutamide, abiraterone. Reagents for AR signaling, splice variants (AR-V7), and resistance studies.
Antibodies
TMPRSS2-ERG
Gene Fusion
Present in ~50% of prostate cancers. Anti-ERG (400+) and anti-TMPRSS2 (13) antibodies for fusion detection by IHC and WB.
Antibodies • Proteins
STEAP1
Six-Transmembrane Protein
Emerging ADC target with high prostate cancer specificity. 16 STEAP-family antibodies and recombinant proteins available.
Antibodies • Proteins
PD-L1 / PTEN
Immune & Tumor Suppressor
PD-L1 for immunotherapy stratification; PTEN loss associated with aggressive disease and PI3K/AKT pathway activation.
Antibodies • Proteins • Biosimilars

Why Researchers Choose abinScience for Prostate Cancer

PSA Immunoassay DevelopmentAnti-PSA antibodies with ELISA validation and recombinant PSA proteins. Contact us for pairing recommendations.
PSMA Theranostics SupportAnti-PSMA/FOLH1 antibodies and recombinant ectodomains for radioligand therapy R&D, PET tracer development, and ADC drug screening.
AR Pathway ProfilingAntibodies targeting AR, AR-V7, and downstream effectors for studying castration-resistant prostate cancer (CRPC) mechanisms and drug resistance.
Protein–Antibody–Kit WorkflowSame target as recombinant protein, detection antibody, and ELISA kit from one manufacturer for streamlined assay development.
Original Manufacturer PricingDirect-from-manufacturer pricing with no distributor markup. Bulk and custom conjugation options available.

Common Research Applications

  1. PSA screening assay development: Anti-PSA antibodies with ELISA and FCM validation, plus recombinant PSA proteins, available for immunoassay development.
  2. PSMA-targeted therapy R&D: Research-grade PSMA biosimilar proteins with ELISA and FACS validation available for comparability and binding studies.
  3. CRPC resistance mechanisms: Profile AR, AR-V7 splice variant, and PTEN/PI3K/AKT signaling with our antibodies (WB, IHC) to study enzalutamide and abiraterone resistance.
  4. Fusion gene detection: Use anti-ERG antibodies (IHC) as a surrogate marker for TMPRSS2-ERG fusion status in prostate cancer tissue specimens.

Documents & QC Data

Download product datasheets, validation images (WB/IHC/IF/FC), CoA, and application protocols on each product page. All data is lot-specific.

FAQs

Do you offer matched PSA antibody pairs for ELISA?

Yes. Anti-PSA/KLK3 monoclonal clone SAA0506 with ELISA, Blocking, and FC validation (available in FITC/APC/PE/PerCP conjugates). Polyclonal antibodies and recombinant PSA proteins also available.

Which PSMA antibodies work for flow cytometry?

Research-grade PSMA/FOLH1 biosimilar antibodies (e.g., pasotuxizumab) with ELISA and FACS validation. Anti-PSMA polyclonal antibodies also available.

Do you have AR-V7 splice variant reagents?

We offer anti-AR polyclonal and monoclonal antibodies. See product pages for validated applications and species reactivity.

What reagents are available for STEAP1 ADC development?

We carry anti-STEAP1 antibodies and recombinant STEAP1 proteins for target validation, cell-surface expression profiling, and binding characterization in ADC research.

Can I get custom antibodies for novel targets?

Yes — our parent company AtaGenix provides full custom antibody development from immunogen design through hybridoma production and characterization, including targets not yet in our catalog.

186 product results for "Prostate Cancer"

Options+
Options
Confirm
  • Product types
    0 selected
    Antibodies (121)
    Proteins (37)
    Research Biosimiliar (1)
    Research Biosimilar (25)
    Biosimilars (1)
    Stable Cell Lines (1)
  • Expression system
    0 selected
    E. coli (28)
    Mammalian Cells (32)
    Insect Cells (2)
    HEK293T (1)
  • Target
    0 selected
    PSAT1 (1)
    pcnB/Poly(A) polymerase I (1)
    ERG (2)
    FOLH1/PSMA & CD28 (1)
    BPNT1 (1)
    NPEPPS/PSA (2)
    REG3A (1)
    STEAP1 & CD3E (1)
    AMACR (3)
    BRCC3 (1)
    AR/Androgen receptor (3)
    SPOP (2)
    REG3G (2)
    Kv11.1 K+ channel (2)
    FOLH1/PSMA (26)
    FOXA1 (1)
    TMPRSS2 (13)
    FOLH1 (1)
    AREG (2)
    ANXA2 (3)
    ANXA4 (2)
    ACP3 (1)
    PTEN (2)
    BABAM2 (1)
    EDNRA (1)
    EDNRA/ETA/ETRA (7)
    UL42/PAP (8)
    ANXA5 (1)
    AKR7A2 (1)
    F/Fusion glycoprotein F0 (1)
    PASM (1)
    HMG20B (1)
    total PSA/tPSA (4)
    FIP1L1 (1)
    FOLH1/PSMA & CD3E & Albumin/HSA (1)
    SETDB1 (1)
    PSCA (23)
    KCNH2/ERG1 (2)
    BRCA2 (2)
    FOLH1/PSMA & CD3E (3)
    STEAP2 (6)
    ANXA3 (1)
    KCNH7/Kv11.3 K+ channel (3)
    FDXR (1)
    PSA/KLK3 (10)
    STEAP1 (3)
    BCCIP (1)
    oligo/poly-Neu5Ac-PE/Poly-sialicacid (1)
    KLKB1/KLK3 (5)
    CCKAR (1)
    CDK12 (2)
    free PSA/fPSA (3)
    PINK1 (4)
  • Species
    0 selected
    Homo sapiens (Human) (4)
    Human respiratory syncytial virus (HRSV) (1)
    Mus musculus (Mouse) (5)
    Human (53)
    Mouse (1)
    Suid herpesvirus 1 (SuHV-1) (Pseudorabies virus) (2)
  • Applications
    0 selected
    Blocking (2)
    Inhibition (2)
    Functional assay (25)
    Bioactivity: FACS (1)
    Research in vivo (25)
    Functional assay (3)
    Research in vivo (1)
    FuncS (1)
    ELISA (169)
    SDS-PAGE (37)
    FACS (2)
    IF (6)
    IHC (57)
    Immunogen (37)
    GICA (2)
    IP (7)
    FCM (36)
    WB (101)
    Bioactivity testing in progress (26)
    IFA (4)
    Neutralization (3)
    Bioactivity: FACS (25)
  • Reactivity
    0 selected
    Pan troglodytes (2)
    Ovis aries (2)
    Papio hamadryas (1)
    Pongo abelii (2)
    Suid herpesvirus 1 (SuHV-1) (Pseudorabies virus) (2)
    E. coli (1)
    Homo sapiens (Human) (1)
    Pig (5)
    Crocuta crocuta (1)
    Caenorhabditis elegans (1)
    Mouse (24)
    Mus musculus (Mouse) (1)
    Eulemur fulvus collaris (1)
    Dog (5)
    Danio rerio (1)
    Xenopus laevis (2)
    Sheep (1)
    Rat (12)
    Macaca fascicularis (2)
    Bos taurus (5)
    Drosophila melanogaster (1)
    Bovine (2)
    FOLH1/PSMA & CD3E (1)
    Macaca mulatta (1)
    Cervus elaphus (1)
    Xenopus tropicalis (1)
    Oryctolagus cuniculus (2)
    Suid alphaherpesvirus 1 (SuHV-1/PRV) (6)
    Chicken (1)
    General (1)
    Human (92)
  • Host species
    0 selected
    Human (41)
    HEK293T (1)
    Rabbit (42)
    Humanized (6)
    Alpaca (1)
    Chimeric (1)
    Mouse (57)
  • Clonality
    0 selected
    Polyclonal (42)
    Monoclonal (105)
  • Conjugate
    0 selected
    PerCP (7)
    PE (7)
    Unconjugated (87)
    FITC (7)
    APC (7)

Quick access

Contact Us

  • +86-27-65523339

  • info@abinscience.com

  • Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China

  • linkedin
  • Ins
  • youtube
  • youtube
Copyright © 2026 abinScience. All Rights Reserved. All Products are for Research Use Only